Anti-synthetase syndrome-associated interstitial lung disease possibly caused by atezolizumab in a patient with lung adenocarcinoma: a case report

被引：0
|
作者：
Ippei Miyamoto
Tetsuo Shimizu
Ryo Kusahana
Masayuki Nomoto
Daishi Fujiwara
Tsukasa Nishizawa
Kentaro Hayashi
Yoshiko Nakagawa
Yasuhiro Gon
机构：
[1] Nihon University Itabashi Hospital,Department of Respiratory Medicine
[2] Nihon University School of Medicine,undefined
来源：
BMC Pulmonary Medicine | / 23卷
关键词：
Aminoacyl-tRNA synthetase (ARS); Anti-synthetase syndrome (ASS); Interstitial lung disease; Lung cancer; Immune checkpoint inhibitors (ICIs);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Anti-synthetase syndrome-associated interstitial lung disease possibly caused by atezolizumab in a patient with lung adenocarcinoma: a case report
    Miyamoto, Ippei
    Shimizu, Tetsuo
    Kusahana, Ryo
    Nomoto, Masayuki
    Fujiwara, Daishi
    Nishizawa, Tsukasa
    Hayashi, Kentaro
    Nakagawa, Yoshiko
    Gon, Yasuhiro
    BMC PULMONARY MEDICINE, 2023, 23 (01)
  • [2] Prediction of progressive pulmonary fibrosis in patients with anti-synthetase syndrome-associated interstitial lung disease
    Fu, Hongyan
    Zheng, Ziyao
    Zhang, Zhenping
    Yang, Yanjuan
    Cui, Jieda
    Wang, Zhaojun
    Xue, Jing
    Chi, Shuhong
    Cao, Mengshu
    Chen, Juan
    CLINICAL RHEUMATOLOGY, 2023, 42 (07) : 1917 - 1929
  • [3] Prediction of progressive pulmonary fibrosis in patients with anti-synthetase syndrome-associated interstitial lung disease
    Hongyan Fu
    Ziyao Zheng
    Zhenping Zhang
    Yanjuan Yang
    Jieda Cui
    Zhaojun Wang
    Jing Xue
    Shuhong Chi
    Mengshu Cao
    Juan Chen
    Clinical Rheumatology, 2023, 42 : 1917 - 1929
  • [4] Treatment of Interstitial Lung Disease Associated With Myositis and the Anti-Synthetase Syndrome
    Robert W. Hallowell
    Sonye K. Danoff
    Current Treatment Options in Rheumatology, 2018, 4 (4) : 316 - 328
  • [5] Interstitial lung disease as the first manifestation of anti-synthetase syndrome
    Pires, Mario
    Sousa, Magda
    Montez, Ana
    Araujo, Ana
    GALICIA CLINICA, 2014, 75 (01): : 28 - 30
  • [6] Successful baricitinib treatment of refractory anti-synthetase syndrome associated with interstitial lung disease
    Sugino, Keishi
    Ono, Hirotaka
    Saito, Mikako
    Ando, Masahiro
    Tsuboi, Eiyasu
    RESPIROLOGY CASE REPORTS, 2023, 11 (04):
  • [7] Single-Cell Transcriptomics Reveals Peripheral Immune Responses in Anti-Synthetase Syndrome-Associated Interstitial Lung Disease
    Zhu, Lili
    Cao, Zhong
    Wang, Shiyao
    Zhang, Changshui
    Fang, Lei
    Ren, Yanhong
    Xie, Bingbing
    Geng, Jing
    Xie, Sheng
    Zhao, Ling
    Ma, Li
    Dai, Huaping
    Wang, Chen
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [8] Natural history of indolent-anti-synthetase syndrome-associated interstitial lung disease
    Moda, Mitsuhiro
    Sumikawa, Hiromitsu
    Shintani, Ryota
    Takeuchi, Naoko
    Kagawa, Tomoko
    Takimoto, Takayuki
    Arai, Toru
    RESPIRATORY INVESTIGATION, 2024, 62 (05) : 872 - 878
  • [9] Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China
    Xi Zhan
    Wei Yan
    Ying Wang
    Qing Li
    Xuhua Shi
    Yanli Gao
    Qiao Ye
    BMC Pulmonary Medicine, 21
  • [10] Management and outcomes of interstitial lung disease associated with anti-synthetase syndrome: a systematic literature review
    Kouranloo, Koushan
    Dey, Mrinalini
    Elwell, Helen
    Yioe, Veronica
    Spencer, Lisa G.
    Cotton, Caroline, V
    RHEUMATOLOGY, 2024, : 45 - 55
12345